BioSpace News Archive

- BioNJ has released its final speaker roster featuring thought leaders from more than 20 leading biopharmaceutical organizations -- for its Eighth Annual C-Suite Summit, taking place virtually October 30 and November 6 .

Vir Biotechnology, Inc. (Nasdaq: VIR) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that Phil Pang, M.D., Ph.D., Chief Medical Officer of Vir, and Vasant Jadhav, Ph.D., Vice President, Research at Alnylam, will jointly participate in a virtual fireside chat at the H.C. Wainwright Hepatitis B Virus Mini-Conference on Tuesday, October 20, 2020 at 9:30 am PT/ 12:30 pm ET via webcast. A live webcast of the p

Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the third quarter ended September 30, 2020 after market close on Tuesday, November 10, 2020. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific T

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™ (nalbuphine ER) to treat serious neurologically mediated conditions, today announced the appointment of Shashank Rohatagi, Ph.D., as Vice President, Pharmacology and Clinical Pharmacokinetics, Farrell Simon, Pharm.D., as Vice President, Head of U.S. Marketing, and Katherine S. Takaki, Ph.D., as Vice

Company reports $19.5 million in revenue and EPS of ($0.07) in the fourth quarter with significant margin expansion supported by rapid response to COVID-19 market opportunities Q1 21 first two months’ revenue reflect continued positive trend Conference call and live webcast scheduled for today, Tuesday, October 13, 2020 at 4:30 pm (ET)

Mirum Pharmaceuticals, Inc. announced that on October 9, 2020, the Compensation Committee of Mirum’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 74,100 shares of common stock to seven new employees under Mirum’s 2020 Inducement Plan.

10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2020 after market close on Tuesday, November 10, 2020. The company’s management will webcast a corresponding conference call beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: w

The U.S. Food and Drug Administration today posted five warning letters issued to companies marketing dietary supplements containing cesium chloride . In a February 2020 public health alert , the FDA warned consumers and health care professionals to avoid using dietary supplements containing cesium salts, primarily cesium c

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced that it has commenced an underwritten public offering of its common stock.

The American Academy of Family Physicians held elections for its board of directors this week at its annual Congress of Delegates, the organization’s governing body.